140
Participants
Start Date
May 1, 2025
Primary Completion Date
May 1, 2027
Study Completion Date
August 1, 2027
Continuos ceftazidime/avibactam infusion
Continuous infusion will include a loading dose of 2 g/0.5 g administered over 2 hours, followed by continuous infusion of 6 g/1.5 g over 24 hours, equivalent to 0.25 g of ceftazidime per hour. The drug reconstitution and dilution process are shown in Figure 2. The final volume of solution of CZA will be 50 mL, which gives concentration of ceftazidime of 40 mg/mL, with 4:1 concentration ratio for avibactam (10 mg/mL). The solution will be administered via an infusion syringe, with an infusion rate of 6.25 mL/h. Dose adjustments will be applied according to renal function, calculated using Cockroft-Gault formula
Intermitent dosing as per SMPC
Intermittent dosing, as outlined in the SmPC, consists of 2 g/0.5 g administered by prolonged infusion over 2 hours every 8 hours. Dose adjustments will be applied according to renal function, calculated using Cockroft-Gault formula.
UHC Zagreb, Zagreb, Croatia
OTHER_GOV
Daniel Lovrić
UNKNOWN
Mirna Momčilović
UNKNOWN
Ivan Šitum, MD
OTHER